Volume 11, Number 8—August 2005
Research
Multidrug-Resistant Acinetobacter Extremity Infections in Soldiers
Table 1
Patient | Osteomyelitis location | Mechanism of injury | MDR isolate | Bacteremia | Hardware | Parenteral drug therapy | Follow on oral antimicrobial agents | Recurrent infection | Follow-up, wk† |
---|---|---|---|---|---|---|---|---|---|
1 | Left radius/ulna | Landmine explosion, driver of pavement grater | Yes | No | Yes | Imipenem 500 mg every 6 h, amikacin 20 mg/kg/d for 8 wk | No | Secondary infection with MSSA | 12 |
2 | Right humerus/shoulder | IED round through shoulder | Yes | No | Yes | Imipenem 500 mg every 6 h, amikacin 15 mg/kg/d for 6 wk | Yes, ciprofloxacin 500 mg 2 × a day | No | 32 |
3 | Right humerus/shoulder | IED blast, shrapnel injury | Yes | No | Yes | Imipenem 500 mg every 6 h, amikacin 15 mg/kg/d for 7 wk | No | No | 35 |
4 | Left radius/ulna | Gunner in APC who received RPG blast | Yes | Yes | No | Imipenem 500 mg every 6 h for 7 wk, with amikacin 20 mg/kg/d for 3 wk changed to amp/sulb 3 g every 6 h for 4 wk | No | No | 4 |
5 | Left tibia | Mortar blast, shrapnel injuries | Yes | No | No | Ceftazidime 2 g every 8 h; amikacin 12.5 mg/kg/d for 7 wk | No | No | 7 |
6 | Right distal humerus/elbow | Passenger in HMMWV, roadside IED blast | Yes | No | Yes | Imipenem 500 mg every 6 h for 7 wk | No | Secondary infection with Enterobacter cloacae | 22 |
7 | Left tibia/fibula | Proximate IED blast | Yes | No | Yes | Amp/sulb 12 g continuous 24-h infusion for 6 wk | No | No | 36 |
8 | Left humerus | Proximate mortar round blast | Yes | Yes | No | Meropenem 1 g every 8 h for 7 wk | No | No | 5 |
9 | Left tibia/fibula | Driver of Humvee, hit land mine | Yes | No | No | Gentamicin 5 mg/kg/d for 3 wk | No | No | 40 |
10 | Left distal humerus/elbow | Truck driver, IED blast | Yes | No | Yes | Imipenem 500 mg every 6 h for 6 wk | No | Yes—secondary pin tract infection, No culture | 30 |
11 | Right humerus/shoulder | Gunner in HMMWV, IED blast | Yes | No | No | None | No | No | 39 |
12 | Right humerus/elbow | HMMWV passenger, IED blast | No | No | Yes | Imipenem 500 mg every 6 h, amikacin 15 mg/kg/d for 6 wk | No | Secondary infection with MRSA | 48 |
13 | Left tibia | 50-caliber gunshot wound | No | No | No | Amp/sulb 3 g every 6 h, amikacin 20 mg/kg/d for 6 wk | Yes—amox/clav 875/125 mg 2 ×/d for 3 wk | Secondary infection with MSSA | 61 |
14 | Left humerus/elbow | Motor vehicle accident, elbow out window, no blast injury | No | No | Yes | Imipenem 500 mg every 6 h, gentamicin 5 mg/kg/d for 4 d | Yes—levofloxacin 500 mg/d for 10 d | No | 57 |
15 | Right femur | Passenger HMMWV, RPG round to right leg | No | Yes | No | Imipenem 500 mg every 6 h, amikacin 20 mg/kg/d for 6 wk | No | No | 9 |
16 | Left tibia | Gunshot wound to left leg | No | No | No | Imipenem 500 mg every 6 h, amikacin 15 mg/kg/d for 8 wk | No | No | 35 |
17 | Right tibia/fibula | Passenger HMMWV, IED blast, open fracture | No | No | No | Imipenem 500 mg every 6 h for 4 wk, followed by meropenem 1 g every 8 h for 2 more wk | No | Secondary infection with MRSA | 50 |
18 | Left tibia | Motor vehicle accident, run over by tank | No | No | No | Ceftazidime 2 g every 8 h for 4 wk | No | No | 56 |
*MDR, multidrug resistant; MSSA, methicillin-sensitive Staphylococcus aureus; IED, improvised explosive device; APC, armored personnel carrier; RPG, rocket-propelled grenade; HMMWV, high mobility multipurpose wheeled vehicle, also known as Humvee; MRSA, methicillin-resistant S. aureus; Amp/sulb, ampicillin/sulbactam; Amox/clav, Amoxicillin + clavulanic acid.
†Length of follow-up after completion of antimicrobial drug therapy.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.